mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.03 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.05 |